SERIES OF METABOLITES AS BIOMARKERS FOR THE DIAGNOSIS OF PANCREATIC CANCER

The present invention is comprised in the field of medicine, pharmacology, chemistry, biochemistry and biotechnology, and it relates to different series of metabolites present in serum capable of differentiating healthy patients from patients with pancreatic cancer (PC). The invention has an applica...

Full description

Saved in:
Bibliographic Details
Main Authors PRADOS SALAZAR, Jose Carlos, HERRERA MALDONADO, Luis Javier, MARTÍN BLÁZQUEZ, Ariadna, PÉREZ DEL PALACIO, José, MELGUIZO ALONSO, Consolación, CABA PÉREZ, Octavio, VICENTE PÉREZ, María Francisca, DÍAZ NAVARRO, Caridad, PERAZZOLI, Gloria, MARTÍNEZ GALÁN, Joaquina, CABEZA MONTILLA, Laura, ROJAS RUIZ, Ignacio, JIMÉNEZ LUNA, Cristina, MARTÍN RUIZ, José Luis, DIEGUEZ CASTILLO, Carmelo, ORTIZ QUESADA, Raúl, RAMA BALLESTEROS, Ana Rosa
Format Patent
LanguageEnglish
French
Published 24.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is comprised in the field of medicine, pharmacology, chemistry, biochemistry and biotechnology, and it relates to different series of metabolites present in serum capable of differentiating healthy patients from patients with pancreatic cancer (PC). The invention has an application in the clinical diagnosis of a pathology such as PC. La présente invention s'inscrit dans le domaine de la médecine, de la pharmacologie, de la chimie, de la biochimie et de la biotechnologie, et elle concerne différentes séries de métabolites présentes dans le sérum pouvant différencier des patients sains de patients atteints d'un cancer du pancréas (PC). L'invention a une application dans le diagnostic clinique d'une pathologie telle que PC.
Bibliography:Application Number: WO2020EP67255